<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Advancing Real-World Evidence Program</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Advancing Real-World Evidence Program</h1>
    <p class="timestamp">Published: 2022-10-20 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the Advancing Real-World Evidence (RWE) Program to fulfill FDA's commitment under the seventh iteration of the Prescription Drug User Fee Amendments (PDUFA VII), incorporated as part of the FDA User Fee Reauthorization Act of 2022.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-22795</p>
    <p><strong>Publication Date:</strong> 2022-10-20</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/10/20/2022-22795/advancing-real-world-evidence-program">https://www.federalregister.gov/documents/2022/10/20/2022-22795/advancing-real-world-evidence-program</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-22795</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
